Related Experiment Videos
Development of Antistaphylococcal Vaccines
1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. E- mail: jean.lee@channing.harvard.edu
Current Infectious Disease Reports
|November 28, 2001
Summary
Developing a vaccine against Staphylococcus aureus is crucial due to rising antibiotic resistance. Promising vaccine candidates targeting adhesins and toxins are under investigation for high-risk individuals.
Area of Science:
- Infectious Diseases
- Vaccinology
- Microbiology
Background:
- Staphylococcus aureus is a common cause of hospital and community infections.
- Antibiotic resistance in S. aureus complicates treatment options.
- There is a critical need for effective vaccines against S. aureus.
Purpose of the Study:
- To review the development of a multicomponent vaccine against S. aureus.
- To identify promising vaccine candidates for S. aureus infections.
Main Methods:
- Evaluation of vaccine candidates in animal models.
- Assessment of vaccine candidates in human clinical trials.
Main Results:
- Several vaccine candidates are under active investigation.
- Promising candidates include adhesins (fibronectin-binding protein, collagen-binding protein, fibrinogen-binding protein), a nontoxic alpha toxin mutant, and capsular polysaccharides (types 5 and 8).
Conclusions:
- The development of a multicomponent vaccine against S. aureus is a priority.
- Targeting adhesins, toxins, and capsular polysaccharides shows promise for S. aureus vaccine development.